Jiangsu Quality Horizons Pharmtech Co., Ltd.

http://www.yabang-qhpharm.com/

Jiangsu Quality Horizons Pharmtech Co., Ltd.(abbreviated as QH Pharm) is specialized in R&D, manufacturing, sales and marketing of Anthelmintic products. Currently QH Pharm owns two manufacturing sites, i.e. Changzhou Yabang-QH Pharmachem Co., Ltd. and Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd.. The group head quarter is located in Changzhou with R&D center, sales center, procurement center and supply chain center, responsible for all such activities in the group.

Complete and effective quality system and EHS system ensures the company's standardized operation. The quality system successfully inspected by WHO, EDQM and US FDA, and obtained EU-GMP certificate. Many APIs registered in EU markets with ASMFs and CEPs, some products registered in FDA with VMFs. The company maintains valid authentication on ISO14001 Environmental Protection Management System and OSHAS18001 EHS System since 2007, and also had positive customer EHS audits and third party EHS audits results as well as social responsibility audits since 2007. The group continuously is investing in EHS, automation and informatization so as to insure the EHS and working environment meeting all the regulations.

R & D is the lifeline of enterprises. In order to expedite the R&D speed of new products, the company set up the Group R&D center with lab trial center and Kilo-lab facility, also founded Jiangsu Provincial Engineering & Technology Research Center for Anthelmintic Drugs with the local government, specializing in the R&D of Anthelmintic Products. The R&D center equipped with advanced test instruments such as Prepare LC-MS and LC-DAD. We also closely cooperate with several Chinese Scientific Research Institutes, and now working on several "Jiangsu Provincial Science & Technology Innovation Projects" and "State Spark Program Projects". For many years, it offers contract development on high value intermediates, more than 20 generic APIs and also has 27 patents. The group continuously invests on R&D and focus on generic APIs with green process innovation, high barrier APIs and New Formulations for Pets.

The company focuses on Anthelmintic Products，also developed other high value new products，exporting to more than 100 countries. We also offer contract manufacturing services for international big pharmaceutical companies on advanced new drug intermediates and APIs, and maintain long term strategic cooperation relationship with them. We are committed to providing superior quality products, cost effective solutions and innovative technologies to enable customers long-term market success.